Fusion Pharmaceuticals Inc. Restricted Cash, Current
Fusion Pharmaceuticals Inc. had Restricted Cash, Current of $469.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2024-05-07
- 2024-03-31: Restricted Cash, Current $469.00K.
- 2023-12-31: Restricted Cash, Current $469.00K.
- 2023-09-30: Restricted Cash, Current $469.00K.
- 2023-06-30: Restricted Cash, Current $419.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2024-03-31 | $469.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $469.00K 10-Q · filed 2024-05-07 |
| 2023-09-30 | $469.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $419.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $419.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $454.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $429.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $429.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $429.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $669.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $669.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $669.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $669.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $425.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $280.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $280.00K 10-Q · filed 2020-08-11 |
| 2019-12-31 | $280.00K 10-K · filed 2021-03-25 |